MARKETING / BRANDS

Fight against Novel Coronavirus - COVID-19

LOPIRAVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Manufactured by J Duncan Healthcare Pvt. Ltd Marketed by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

TINAROVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Marketed and Manufactured by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

Marketing Brands : Strategically Lok-Beta's key strength and invest significant area based on 3 point agenda

1. Offer opportunities to our associates to run a small to medium sized profitable entrepreneurship by offering them technical know-how with the     empowerment and accountability within the core values and system of the company.

2. Aiming to enable service towards broader segment of the pharmaceuticals & healthcare markets.

3. Marketing strategy - Lok-Beta chooses to market its products which matches its rigorous marketing, stringent quality norms and financial return     criteria.

Methodology : The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.

International Market : The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.

• CIS : Armenia, Belarus, Kazakhstan, Kirgizstan, Russia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan
• Asia Pacific: Bhutan, Sri-Lanka, Myanmar, Philippines, Thailand, Vietnam, Yemen, Malaysia, Indonesia, Singapore
• Latin America: Bolivia, Guatemala, Paraguay, Trinidad, Brazil, Colombia, Argentina, Nicaragua, Chili, Costa Rica
• Africa: Ethiopia, Namibia, Nigeria

Domestic Market : Branch offices at 4 state enable expending own domestic business in Maharashtra, Uttar-Pradesh, Bihar and Jharkhand. Aggressive plan for PAN India operation are under implementation.

Brands :

• Lok-Beta has launched new products in the market such as Movnic D Plus, Kouf – X DS, Lozit Suspension and planning to launch products of niche segments.
• Lok-Beta is a key player in the Indian market, with a wide range of products in various segments such as Antiinflammatory, Neutraceuticals, Antimalarial and Antihypertensive.
• Lok-Beta enjoys a strong rapport with the medical profession including specialist, who have accepted Lok-Beta's product for their High quality, efficacy and affordability.
• Lok-Beta has built up a strong equity with a vast and efficient DEALER NETWORK.